38 related articles for article (PubMed ID: 15374963)
1. Tumor-specific memory CD8
Liu Q; Ran L; Yue Z; Su X; Wang L; Wen S; Lei S; Yang X; Zhang Y; Hu J; Tang J; Li Z; Hu L; Zhu B; Xu L; Ye L; Huang Q
Cell Mol Immunol; 2023 Apr; 20(4):423-426. PubMed ID: 36859455
[No Abstract] [Full Text] [Related]
2. TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective.
Nixon BG; Gao S; Wang X; Li MO
Nat Rev Immunol; 2023 Jun; 23(6):346-362. PubMed ID: 36380023
[TBL] [Abstract][Full Text] [Related]
3. Heparanase and the hallmarks of cancer.
Jayatilleke KM; Hulett MD
J Transl Med; 2020 Nov; 18(1):453. PubMed ID: 33256730
[TBL] [Abstract][Full Text] [Related]
4. TGF-β in T Cell Biology: Implications for Cancer Immunotherapy.
Dahmani A; Delisle JS
Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29891791
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.
Sanjabi S; Oh SA; Li MO
Cold Spring Harb Perspect Biol; 2017 Jun; 9(6):. PubMed ID: 28108486
[TBL] [Abstract][Full Text] [Related]
6. A patient-specific therapeutic approach for tumour cell population extinction and drug toxicity reduction using control systems-based dose-profile design.
Kapoor S; Rallabandi VP; Sakode C; Padhi R; Roy PK
Theor Biol Med Model; 2013 Dec; 10():68. PubMed ID: 24369857
[TBL] [Abstract][Full Text] [Related]
7. TGF-β signalling is required for CD4⁺ T cell homeostasis but dispensable for regulatory T cell function.
Sledzińska A; Hemmers S; Mair F; Gorka O; Ruland J; Fairbairn L; Nissler A; Müller W; Waisman A; Becher B; Buch T
PLoS Biol; 2013 Oct; 11(10):e1001674. PubMed ID: 24115907
[TBL] [Abstract][Full Text] [Related]
8. Truncated form of TGF-βRII, but not its absence, induces memory CD8+ T cell expansion and lymphoproliferative disorder in mice.
Ishigame H; Mosaheb MM; Sanjabi S; Flavell RA
J Immunol; 2013 Jun; 190(12):6340-50. PubMed ID: 23686479
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma-like T cell infiltration in liver is associated with increased copy number of dominant negative form of TGFβ receptor II.
Zhang W; Tsuda M; Yang GX; Tsuneyama K; He XS; Ansari AA; Ridgway WM; Coppel RL; Lian ZX; Leung PS; Gershwin ME
PLoS One; 2012; 7(11):e49413. PubMed ID: 23145171
[TBL] [Abstract][Full Text] [Related]
10. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive.
Coschi CH; Martens AL; Ritchie K; Francis SM; Chakrabarti S; Berube NG; Dick FA
Genes Dev; 2010 Jul; 24(13):1351-63. PubMed ID: 20551166
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the hurdles in using mouse genetic models that block TGF-beta signaling.
Sanjabi S; Flavell RA
J Immunol Methods; 2010 Feb; 353(1-2):111-4. PubMed ID: 20060833
[TBL] [Abstract][Full Text] [Related]
12. Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody.
Terabe M; Ambrosino E; Takaku S; O'Konek JJ; Venzon D; Lonning S; McPherson JM; Berzofsky JA
Clin Cancer Res; 2009 Nov; 15(21):6560-9. PubMed ID: 19861451
[TBL] [Abstract][Full Text] [Related]
13. Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
Kim S; Buchlis G; Fridlender ZG; Sun J; Kapoor V; Cheng G; Haas A; Cheung HK; Zhang X; Corbley M; Kaiser LR; Ling L; Albelda SM
Cancer Res; 2008 Dec; 68(24):10247-56. PubMed ID: 19074893
[TBL] [Abstract][Full Text] [Related]
14. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.
Williams KM; Gress RE
Best Pract Res Clin Haematol; 2008 Sep; 21(3):579-96. PubMed ID: 18790456
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers.
Wallace A; Kapoor V; Sun J; Mrass P; Weninger W; Heitjan DF; June C; Kaiser LR; Ling LE; Albelda SM
Clin Cancer Res; 2008 Jun; 14(12):3966-74. PubMed ID: 18559619
[TBL] [Abstract][Full Text] [Related]
16. T cell immune reconstitution following lymphodepletion.
Williams KM; Hakim FT; Gress RE
Semin Immunol; 2007 Oct; 19(5):318-30. PubMed ID: 18023361
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice.
Lucas PJ; Kim SJ; Mackall CL; Telford WG; Chu YW; Hakim FT; Gress RE
Blood; 2006 Oct; 108(8):2789-95. PubMed ID: 16788095
[TBL] [Abstract][Full Text] [Related]
18. Role of transforming growth factor-beta in hematologic malignancies.
Dong M; Blobe GC
Blood; 2006 Jun; 107(12):4589-96. PubMed ID: 16484590
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis.
Lucas PJ; McNeil N; Hilgenfeld E; Choudhury B; Kim SJ; Eckhaus MA; Ried T; Gress RE
Cancer Res; 2004 Sep; 64(18):6524-9. PubMed ID: 15374963
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
